Pouchitis and Pouch Dysfunction
Tóm tắt
Từ khóa
Tài liệu tham khảo
Dhillon, 2005, The natural history of surgery for ulcerative colitis in a population-based cohort from Olmsted County, Minnesota, Am J Gastroenterol, 100, A819
Sandborn, 1994, Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment, Gastroenterology, 107, 1856, 10.1016/0016-5085(94)90832-X
Winther, 2003, Survival and cause-specific mortality in ulcerative colitis - follow-up of a population-based cohort in Copenhagen County, Gastroenterology, 125, 1576, 10.1053/j.gastro.2003.09.036
Tulchinsky, 2003, Long-term failure after restorative proctocolectomy for ulcerative colitis, Ann Surg, 238, 229, 10.1097/01.sla.0000082121.84763.4c
Belliveau, 1999, Ileoanal anastomosis with reservoirs: complications and long-term results, Can J Surg, 42, 345
Hueting, 2005, Results and complications after ileal pouch anal anastomosis: a meta-analysis of 43 observational studies comprising 9,317 patients, Dig Surg, 22, 69, 10.1159/000085356
Sagap, 2006, Factors associated with failure in managing pelvic sepsis after ileal pouch-anal anastomosis (IPAA) – a multivariate analysis, Surgery, 140, 691, 10.1016/j.surg.2006.07.015
Prudhomme, 2006, Causes and outcomes of pouch excision after restorative proctocolectomy, Br J Surg, 93, 82, 10.1002/bjs.5147
Nicholls, 2002, Review article: ulcerative colitis-surgical indications and treatment, Aliment Pharmacol Ther, 16, 25, 10.1046/j.1365-2036.16.s4.5.x
Shen, 2005, Comprehensive evaluation of inflammatory and non-inflammatory sequelae of ileal pouch-anal anastomosis, Am J Gastroenterol, 100, 93, 10.1111/j.1572-0241.2005.40778.x
Penna, 1996, Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis, Gut, 38, 234, 10.1136/gut.38.2.234
Fazio, 1995, Ileal pouch-anal anastomosis complications and function in 1005 patients, Ann Surg, 222, 120, 10.1097/00000658-199508000-00003
Ferrante, 2008, Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis, Inflamm Bowel Dis, 14, 20, 10.1002/ibd.20278
Fleshner, 2008, Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis, Clin Gastroenterol Hepatol, 6, 561, 10.1016/j.cgh.2008.01.002
Stocchi, 2001, Pouch and pouchitis, Gastroenterol Clin North Am, 30, 223, 10.1016/S0889-8553(05)70175-8
Gionchetti, 2003, Prophylaxis of pouchitis onset with probiotic therapy: a double-blind placebo controlled trial, Gastroenterology, 124, 1202, 10.1016/S0016-5085(03)00171-9
Abdelrazeq, 2008, Predictors for acute and chronic pouchitis following restorative proctocolectomy for ulcerative colitis, Colorectal Dis, 10, 805, 10.1111/j.1463-1318.2007.01413.x
Penna, 1993, Function of ileal J pouch-anal anastomosis in patients with familial adenomatous polyposis, Br J Surg, 80, 765, 10.1002/bjs.1800800638
Tjandra, 1993, Similar functional results after restorative proctocolectomy in patients with familial adenomatous polyposis and mucosal ulcerative colitis, Am J Surg, 165, 322, 10.1016/S0002-9610(05)80834-7
Shen, 2008, Clostridium difficile infection in patients with ileal pouch-anal anastomosis, Clin Gastroenterol Hepatol, 6, 782, 10.1016/j.cgh.2008.02.021
Munoz-Juarez, 1999, Misdiagnosis of specific cytomegalovirus infection of ileoanal pouch as a refractory idiopathic chronic pouchitis. Report of two cases, Dis Colon Rectum, 42, 117, 10.1007/BF02235196
Mooka, 1998, Pouchitis associated with primary cytomegalovirus infection, Am J Gastroenterol, 93, 264, 10.1111/j.1572-0241.1998.00264.x
Kühbacher, 2006, Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis, Gut, 55, 833, 10.1136/gut.2005.078303
Ohge, 2005, Association between fecal hydrogen sulfide production and pouchitis, Dis Colon Rectum, 48, 469, 10.1007/s10350-004-0820-8
Gosselink, 2004, Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis, Dis Colon Rectum, 47, 1519, 10.1007/s10350-004-0623-y
Falk, 2007, Ileal pelvic pouch microbiota from two former ulcerative colitis patients, analysed by DNA-based methods, were unstable over time and showed the presence of Clostridium perfringens, Scand J Gastroenterol, 42, 973, 10.1080/00365520701204238
Komanduri, 2007, Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation, Clin Gastroenterol Hepatol, 5, 352, 10.1016/j.cgh.2007.01.001
Kroesen, 2006, Increased bacterial permeation in long-lasting ileoanal pouches, Inflamm Bowel Dis, 12, 736, 10.1097/00054725-200608000-00010
DeSilva, 1991, Lymphocyte and macrophage subpopulations in pelvic ileal reservoirs, Gut, 32, 1160, 10.1136/gut.32.10.1160
Hirata, 1986, Immunohistological characterization of intraepithelial and lamina propria lymphocytes in control ileum and colon and inflammatory bowel disease, Dig Dis Sci, 31, 593, 10.1007/BF01318690
Stallmach, 1998, Increased state of activation of CD4 positive T cells and elevated interferon gamma production in pouchitis, Gut, 43, 499, 10.1136/gut.43.4.499
Thomas, 2001, Altered expression of the lymphocyte activation markers CD30 and CD27 in patients with pouchitis, Scand J Gastroenterol, 36, 258, 10.1080/003655201750074519
Goldberg, 1996, Leukocyte typing, cytokine expression and epithelial turnover in the ileal pouch in patients with ulcerative colitis and familial adenomatous polyposis, Gut, 38, 549, 10.1136/gut.38.4.549
Kroesen, 2008, Permanently increased mucosal permeability in patients with backwash ileitis after ileoanal pouch for ulcerative colitis, Scand J Gastroenterol, 43, 704, 10.1080/00365520701873206
Cario, 2000, Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease, Infect Immun, 68, 7010, 10.1128/IAI.68.12.7010-7017.2000
Toiyama, 2006, The expression patterns of toll-like receptors in the ileal pouch mucosa of postoperative ulcerative colitis patients, Surg Today, 36, 287, 10.1007/s00595-005-3144-y
Heuschen, 2007, Differential expression of toll-like receptor 3 and 5 in ileal pouch mucosa of ulcerative colitis patients, Int J Colorectal Dis, 22, 293, 10.1007/s00384-006-0133-6
Lammers, 2005, Combined carriership of TLR9 -1237C and CD14 -260T alleles enhances the risk for developing chronic relapsing pouchitis, World J Gastroenterol, 11, 7323, 10.3748/wjg.v11.i46.7323
Ayabe, 2000, Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria, Nat Immunol, 1, 113, 10.1038/77783
Salzman, 2003, Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin, Nature, 422, 522, 10.1038/nature01520
Ouellette, 2001, Paneth cell defensins and innate immunity of the small bowel, Inflamm Bowel Dis, 7, 43, 10.1097/00054725-200102000-00007
Ghosh, 2002, Paneth cell trypsin is the processing enzyme for human defensin-5, Nat Immunol, 3, 583, 10.1038/ni797
Porter, 1997, Broad spectrum antimicrobial activity of human intestinal defensin 5, Infect Immun, 65, 2396, 10.1128/IAI.65.6.2396-2401.1997
Wehkamp, 2005, Decreased Paneth cell defensins and antimicrobial activity in ileal Crohn's disease, Proc Natl Acad Sci U S A, 102, 18129, 10.1073/pnas.0505256102
Kiehne, 2006, Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli, World J Gastroenterol, 12, 1056, 10.3748/wjg.v12.i7.1056
Hirata, 2008, Proliferation of immature plasma cells in pouchitis mucosa in patients with ulcerative colitis, Inflamm Bowel Dis, 14, 1084, 10.1002/ibd.20447
Patel, 1995, Cytokine production in pouchitis is similar to that in ulcerative colitis, Dis Colon Rectum, 38, 831, 10.1007/BF02049839
Schmidt, 2006, Increased cytokine transcripts in pouchitis reflect the degree of inflammation but not the underlying entity, Int J Colorectal Dis, 21, 419, 10.1007/s00384-005-0024-2
Gionchetti, 1994, Mucosal concentrations of interleukin-1β, interleukin-6, interleukin-8, and tumor necrosis factor-α in pelvic ileal pouches, Dig Dis Sci, 39, 1525, 10.1007/BF02088059
Bulois, 2000, Pouchitis is associated with mucosal imbalance between interleukin-8 and interleukin-10, Inflamm Bowel Dis, 6, 157, 10.1002/ibd.3780060302
Patel, 1995, Circulating soluble adhesion molecules in inflammatory bowel disease, Eur J Gastroenterol Hepatol, 7, 1037, 10.1097/00042737-199511000-00005
Chaussade, 1991, Presence of PAF-acether in stool of patients with pouch ileoanal anastomosis and pouchitis, Gastroenterology, 100, 1509, 10.1016/0016-5085(91)90646-3
Gertner, 1994, Increased leukotriene B4 release from ileal pouch mucosa in ulcerative colitis compared with familial adenomatous polyposis, Gut, 35, 1429, 10.1136/gut.35.10.1429
Romano, 2007, Vascular endothelial growth factor and cyclooxygenase-2 are overexpressed in ileal pouch-anal anastomosis, Dis Colon Rectum, 50, 650, 10.1007/s10350-006-0807-8
Stucchi, 2003, A neurokinin 1 receptor antagonist reduces an ongoing ileal pouch inflammation and the response to a subsequent inflammatory stimulus, Am J Physiol Gastrointest Liver Physiol, 285, G1259, 10.1152/ajpgi.00063.2003
Stallmach, 2000, Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis, Gut, 47, 415, 10.1136/gut.47.3.415
Ulisse, 2001, Expression of cytokine, inducible nitric oxide synthase, matrix metalloproteinases in pouchitis: effects of probiotic therapy, Am J Gastroenterol, 96, 2691, 10.1111/j.1572-0241.2001.04139.x
Leal, 2008, Differential expression of pro-inflammatory cytokines and a pro-apoptotic protein in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis, Tech Coloproctol, 12, 33, 10.1007/s10151-008-0395-9
Thomas, 1999, Increased mucosal IFN-γ production in pouchitis despite normal functional responses of isolated CD4 cells, Gut, 44, 32A
Shepherd, 1993, Distribution of mucosal morphology and an assessment of colonic phenotype change in the pelvic ileal reservoir, Gut, 34, 101, 10.1136/gut.34.1.101
Biancone, 2003, Tropomyosin expression in the ileal pouch: a relationship with the development of pouchitis in ulcerative colitis, Am J Gastroenterol, 98, 2719, 10.1111/j.1572-0241.2003.08719.x
Coffey, 2009, Pathogenesis of and unifying hypothesis for idiopathic pouchitis, Am J Gastroenterol, 104, 1013, 10.1038/ajg.2008.127
De Preter, 2009, Pouchitis, similar to active ulcerative colitis, is associated with impaired butyrate oxidation by intestinal mucosa, Inflamm Bowel Dis, 15, 335, 10.1002/ibd.20768
Tysk, 1991, Colonic glycoproteins in monozygote twins with inflammatory bowel disease, Gastroenterology, 100, 1509, 10.1016/0016-5085(91)90211-3
Carter, 2001, The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis, Gastroenterology, 121, 805, 10.1053/gast.2001.28017
Meier, 2005, Innate immune receptor genetic polymorphisms in pouchitis: is NOD2/CARD15 a susceptibility factor?, Inflamm Bowel Dis, 11, 965, 10.1097/01.MIB.0000186407.25694.cf
Schmidt, 1998, Pre-operative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure, Ann Surg, 227, 654, 10.1097/00000658-199805000-00006
Achkar, 2005, Differentiating risk factors for acute and chronic pouchitis, Clin Gastroenterol Hepatol, 3, 60, 10.1016/S1542-3565(04)00604-4
Okon, 2005, Elevated platelet count before ileal pouch–anal anastomosis for ulcerative colitis is associated with the development of chronic pouchitis, Am Surg, 71, 821, 10.1177/000313480507101005
Hata, 2003, Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis – multivariate analysis, Scand J Gastroenterol, 38, 1055, 10.1080/00365520310005938
Lepistö, 2008, Prevalence of primary sclerosing cholangitis in ulcerative colitis patients undergoing proctocolectomy and ileal pouch-anal anastomosis, Inflamm Bowel Dis, 14, 775, 10.1002/ibd.20384
Shen, 2006, Risk factors for diseases of ileal pouch-anal anastomosis in patients with ulcerative colitis, Clin Gastroenterol Hepatol, 4, 81, 10.1016/j.cgh.2005.10.004
Fleshner, 2001, High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis, Gut, 49, 671, 10.1136/gut.49.5.671
Kuisma, 2004, Factors associated with disease activity of pouchitis after surgery for ulcerative colitis, Scand J Gastroenterol, 39, 544, 10.1080/00365520410004668
Hoda, 2008, Predictors of pouchitis after ileal pouch-anal anastomosis: a retrospective review, Dis Colon Rectum, 51, 554, 10.1007/s10350-008-9194-7
Fleshner, 2007, A prospective multivariate analysis of clinical factors associated with pouchitis after ileal pouch-anal anastomosis, Clin Gastroenterol Hepatol, 5, 952, 10.1016/j.cgh.2007.03.020
Boyko, 1987, Risk of ulcerative colitis among former and current cigarette smokers, N Engl J Med, 316, 707, 10.1056/NEJM198703193161202
Shen, 2009, Association between immune-associated disorders and adverse outcomes of ileal pouch-anal anastomosis, Am J Gastroenterol, 104, 655, 10.1038/ajg.2008.76
Mathis, 2008, Ileal pouch-anal anastomosis and liver transplantation for ulcerative colitis complicated by primary sclerosing cholangitis, Br J Surg, 95, 882, 10.1002/bjs.6210
Cho, 2008, Proctocolectomy-ileal pouch-anal anastomosis for ulcerative colitis after liver transplantation for primary sclerosing cholangitis: a multi-institutional analysis, J Gastrointest Surg, 12, 1221, 10.1007/s11605-008-0528-5
Zins, 1995, Pouchitis disease course after orthotopic liver transplantation in patients with primary sclerosing cholangitis and an ileal pouch-anal anastomosis, Am J Gastroenterol, 90, 2177
Freeman, 2008, Orthotopic liver transplantation for primary sclerosing cholangitis in patients with ulcerative colitis: impact on occurrence of chronic pouchitis, Clin Gastroenterol Hepatol, 6, 62, 10.1016/j.cgh.2007.09.018
Shen, 2001, Endoscopic and histologic evaluations together with symptom assessment are required to diagnose pouchitis, Gastroenterology, 121, 261, 10.1053/gast.2001.26290
Moskowitz, 1986, An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir, Int J Colorectal Dis, 1, 167, 10.1007/BF01648445
Sandborn, 1994, Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index, Mayo Clin Proc, 69, 409, 10.1016/S0025-6196(12)61634-6
Shen, 2007, Effect of withdrawal of non-steroidal anti-inflammatory drug use in patients with the ileal pouch, Dig Dis Sci, 52, 3321, 10.1007/s10620-006-9710-3
Parsi, 2004, Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis, Gastroenterology, 126, 1280, 10.1053/j.gastro.2004.02.012
Lim, 2008, The assessment of a rapid noninvasive immunochromatographic assay test for fecal lactoferrin in patients with suspected inflammation of the ileal pouch, Dis Colon Rectum, 51, 96, 10.1007/s10350-007-9151-x
Parsi, 2008, Cost-effectiveness of quantitative fecal lactoferrin assay for diagnosis of symptomatic patients with ileal pouch-anal anastomosis, J Clin Gastroenterol, 42, 799, 10.1097/MCG.0b013e318074fdfe
Johnson, 2008, Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis, Eur J Gastroenterol Hepatol, 20, 174, 10.1097/MEG.0b013e3282f1c9a7
Johnson, 2009, Faecal M2-pyruvate kinase: a novel, noninvasive marker of ileal pouch inflammation, Eur J Gastroenterol Hepatol, 21, 544, 10.1097/MEG.0b013e3283040cb3
Schmidt, 2007, Irritable pouch syndrome is associated with depressiveness and can be differentiated from pouchitis by quantification of mucosal levels of proinflammatory gene transcripts, Inflamm Bowel Dis, 13, 1502, 10.1002/ibd.20241
Panis, 1996, Ileal pouch-anal anastomosis for Crohn's disease, Lancet, 347, 854, 10.1016/S0140-6736(96)91344-6
Shen, 2002, Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis, Am J Gastroenterol, 97, 972, 10.1111/j.1572-0241.2002.05617.x
Shen, 2008, Enterochromaffin cell hyperplasia in irritable pouch syndrome, Am J Gastroenterol, 103, 2293, 10.1111/j.1572-0241.2008.01990.x
Lohmuller, 1990, Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis, Ann Surg, 211, 622
Mowschenson, 2000, Ileoanal pouch operation: long-term outcome with or without diverting ileostomy, Arch Surg, 135, 463, 10.1001/archsurg.135.4.463
Hurst, 1998, Implications of acute pouchitis on the long-term functional results after restorative proctocolectomy, Inflamm Bowel Dis, 4, 280, 10.1002/ibd.3780040405
Madiba, 2001, Pouchitis following restorative proctocolectomy for ulcerative colitis: incidence and therapeutic outcome, J R Coll Surg Edinb, 46, 334
Sandborn, 1997, Pouchitis: risk factors, frequency, natural history, classification and public health prospective, 51
Shen, 2003, Diagnosis and management of patients with pouchitis, Drugs, 65, 453, 10.2165/00003495-200363050-00002
Croagh, 2007, Pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon, Inflamm Bowel Dis, 13, 1522, 10.1002/ibd.20249
Stahlberg, 1996, Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors, Dis Colon Rectum, 39, 1012, 10.1007/BF02054692
Elahi, 2008, On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials, Dig Dis Sci, 53, 1278, 10.1007/s10620-007-0006-z
Gosselink, 2004, Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG, Dis Colon Rectum, 47, 876, 10.1007/s10350-004-0525-z
Gionchetti, 2000, Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial, Gastroenterology, 119, 305, 10.1053/gast.2000.9370
Mimura, 2004, Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis, Gut, 53, 108, 10.1136/gut.53.1.108
Pronio, 2008, Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells, Inflamm Bowel Dis, 14, 662, 10.1002/ibd.20369
Gionchetti, 2007, High-dose probiotics for the treatment of active pouchitis, Dis Colon Rectum, 50, 2075, 10.1007/s10350-007-9068-4
Shen, 2005, Maintenance therapy with a probiotic in antibiotic-dependent pouchitis – experience in clinical practice, Aliment Pharmacol Ther, 22, 721, 10.1111/j.1365-2036.2005.02642.x
McLaughlin, 2008, VSL#3 for chronic pouchitis; experience in UK clinical practice, Gastroenterology, 134, A711
Madden, 1994, Double-blinded crossover trial of metronidazole versus placebo in chronic unremitting pouchitis, Dig Dis Sci, 39, 1193, 10.1007/BF02093783
Shen, 2001, A randomized trial of ciprofloxacin and metronidazole in treating acute pouchitis, Inflamm Bowel Dis, 7, 301, 10.1097/00054725-200111000-00004
Isaacs, 2007, Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study, Inflamm Bowel Dis, 13, 1250, 10.1002/ibd.20187
McLaughlin, 2008, An open study of antibiotics for the treatment of pre-pouch ileitis following restorative proctocolectomy with ileal pouch-anal anastomosis, Aliment Pharmacol Ther
Araki, 2008, Leukocytapheresis for the treatment of active pouchitis: a pilot study, J Gastroenterol, 43, 571, 10.1007/s00535-008-2199-0
Shen, 2009, The efficacy and tolerability of AST-120 (spherical carbon adsorbent) in active pouchitis, Am J Gastroenterol, 104, 1468, 10.1038/ajg.2009.138
Shen, 2008, Rifaximin for maintenance therapy in antibiotic-dependent pouchitis, BMC Gastroenterol, 8, 26, 10.1186/1471-230X-8-26
Schaus, 2007, Large polyps in the ileal pouch in patients with underlying ulcerative colitis, Dis Colon Rectum, 50, 832, 10.1007/s10350-006-0871-0
Gionchetti, 1999, Antibiotic combination therapy in patients with chronic treatment-resistant pouchitis, Aliment Pharmacol Ther, 13, 713, 10.1046/j.1365-2036.1999.00553.x
Abdelrazeq, 2005, Rifaximin-ciprofloxacin combination therapy is effective in chronic active refractory pouchitis, Colorectal Dis, 7, 182, 10.1111/j.1463-1318.2004.00746.x
Mimura, 2002, Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis, Aliment Pharmacol Ther, 16, 909, 10.1046/j.1365-2036.2002.01203.x
Shen, 2007, Combined ciprofloxacin and tinidazole in the treatment of chronic refractory pouchitis, Dis Colon Rectum, 50, 498, 10.1007/s10350-006-0828-3
Viscido, 2004, Management of refractory fistulizing pouchitis with infliximab, Eur Rev Med Pharmacol Sci, 8, 239
Gionchetti, 2007, Oral budesonide in the treatment of chronic refractory pouchitis, Aliment Pharmacol Ther, 25, 1231, 10.1111/j.1365-2036.2007.03306.x
Calabrese, 2008, Short-term treatment with infliximab in chronic refractory pouchitis and ileitis, Aliment Pharmacol Ther, 27, 759, 10.1111/j.1365-2036.2008.03656.x